Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Jobs
 

EquipNet Auction: Cyteir & Moment Biosciences Late Model Lab Instruments - June 14-15

Sign Up for University of Washington Online Master of Pharmaceutical Bioengineering

Our newest cartoon revisits "Milestones in Polio"


Utah Life Science Industry Directory

NuWest LabTemps: Find your next direct hire or contract employment.

Banner Advertising

Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and delayed by COVID-19, to be launched in 2023 replacing UtahLifeScience.com. Regrettably, we are working with reduced staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved directory upon the launch of the new site. We apologize for the inconvenience.

Myriad Pharmaceuticals, Inc.


Myriad Pharmaceuticals, Inc.
320 Wakara Way
Salt Lake City, UT 84108
Myriad Pharmaceuticals, Inc.
 
Phone: (800) 4-MYRIAD
Fax: (800) 469-7423
Year Established:  1991
Employees: 200
Ticker: MYGN
Exchange: NASDAQ
Main Contact: Mark C. Capone, President & CEO
 
Other Contacts:  Robert G. Harrison, CIO
Patrick Burke, Executive VP, Emerging Products
Gary A. King, Executive VP, International Operations
Johnathan M. Lancaster, CMO
Jerry Lanchbury, CSO
Richard Marsh, Executive VP & General Counsel
 
Company Description
Myriad Genetics is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on five strategic imperatives: build upon a solid hereditary cancer foundation, growing new product volume, expanding reimbursement coverage for new products, increasing RNA kit revenue internationally and improving profitability with Elevate 2020.


Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2023 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

UtahLifeScience.com is owned and published by Info.Resource, Inc.